Cargando…
Old versus New: Why Do We Need New Antiepileptic Drugs?
Achieving complete seizure remission without adverse events is the goal of epilepsy treatment. Recently, many new antiepileptic drugs (AEDs) have been developed. Even though the efficacy of new AEDs is not stronger than that of old AEDs, there are advantages in using new AEDs. They have unique or di...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Epilepsy Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295052/ https://www.ncbi.nlm.nih.gov/pubmed/25625087 |
_version_ | 1782352782857076736 |
---|---|
author | Lee, Sang Kun |
author_facet | Lee, Sang Kun |
author_sort | Lee, Sang Kun |
collection | PubMed |
description | Achieving complete seizure remission without adverse events is the goal of epilepsy treatment. Recently, many new antiepileptic drugs (AEDs) have been developed. Even though the efficacy of new AEDs is not stronger than that of old AEDs, there are advantages in using new AEDs. They have unique or different mechanisms of action that enable the creation of possible synergistic combinations. They usually exhibit fewer or no pharmacokinetic drug interactions. Furthermore, the response to AEDs varies individually. A similar efficacy does not imply a similar response from all patients. Many new AEDs have fewer adverse events, including induction of congenital malformations. Other concerns about the long-term effects of established AEDs, such as bone health and development of atherosclerosis, may be alleviated by the use of new AEDs. New AEDs are needed to achieve better care of patients with epilepsy. |
format | Online Article Text |
id | pubmed-4295052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Korean Epilepsy Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-42950522015-01-26 Old versus New: Why Do We Need New Antiepileptic Drugs? Lee, Sang Kun J Epilepsy Res Review Achieving complete seizure remission without adverse events is the goal of epilepsy treatment. Recently, many new antiepileptic drugs (AEDs) have been developed. Even though the efficacy of new AEDs is not stronger than that of old AEDs, there are advantages in using new AEDs. They have unique or different mechanisms of action that enable the creation of possible synergistic combinations. They usually exhibit fewer or no pharmacokinetic drug interactions. Furthermore, the response to AEDs varies individually. A similar efficacy does not imply a similar response from all patients. Many new AEDs have fewer adverse events, including induction of congenital malformations. Other concerns about the long-term effects of established AEDs, such as bone health and development of atherosclerosis, may be alleviated by the use of new AEDs. New AEDs are needed to achieve better care of patients with epilepsy. Korean Epilepsy Society 2014-12-31 /pmc/articles/PMC4295052/ /pubmed/25625087 Text en Copyright © 2014 Korean Epilepsy Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Lee, Sang Kun Old versus New: Why Do We Need New Antiepileptic Drugs? |
title | Old versus New: Why Do We Need New Antiepileptic Drugs? |
title_full | Old versus New: Why Do We Need New Antiepileptic Drugs? |
title_fullStr | Old versus New: Why Do We Need New Antiepileptic Drugs? |
title_full_unstemmed | Old versus New: Why Do We Need New Antiepileptic Drugs? |
title_short | Old versus New: Why Do We Need New Antiepileptic Drugs? |
title_sort | old versus new: why do we need new antiepileptic drugs? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295052/ https://www.ncbi.nlm.nih.gov/pubmed/25625087 |
work_keys_str_mv | AT leesangkun oldversusnewwhydoweneednewantiepilepticdrugs |